ImmuneMed

Press Release | ImmuneMed

Press Release

Home

Publicity

[Journal of Clinical Medicine] COVID-19 Phase 2 Clinical Study Results

Writer|ImmuneMed

Views |8556

Date|2022-05-26

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_04.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_05.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_06.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_07.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_08.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_09.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_10.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_11.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_12.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_13.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_14.jpg

JCM-hzVSF_COVID-19_%ED%8E%98%EC%9D%B4%EC%A7%80_15.jpg

Prev 및 Next
Prev	[Heliyon] hzVSF inhibits hepatitis B virus infection by targeting viral cell entry 2022-05-26
Next	[Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment 2021-01-08